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Objective: To investigate the association of three single nucleotide polymorphisms (SNPs) in the complement factor H
(CFH), KIAA1109, and interleukin-27 (IL-27) genes in patients with anterior uveitis (AU).
Methods: A case-control study was performed in 98 Chinese AU patients and 308 healthy controls. Three SNPs including
CFH-rs800292, KIAA1109-rs4505848, and IL27-rs4788084 were detected using TaqMan SNP Genotyping Assays.
Analyses were also stratified according to gender, clinical features and human leukocyte antigen (HLA)-B27 status of the
patients.
Results: No significant association was found between all three SNPs and AU. However, when stratified by gender, there
were significant increases in the frequency of the CFH-rs800292 184G allele and GG homozygosity in female patients
compared with control subjects (p=0.003 and p=0.009, respectively). Similar association was not detected in males. No
significant association was found between AU and KIAA1109-rs4505848 or IL27-rs4788084 even stratified by gender.
There was no significant difference in genotypes of AU patients stratified by various clinical features. Subgroup analyses
showed that all three SNPs (rs800292, rs4505848, and rs4788084) were not associated with AU in HLA-B27–positive
patients, neither in HLA-B27–negative patients.
Conclusions: Our results showed an association between AU and CFH polymorphism in Chinese female patients but not
in males, indicating gender-specific genetic differences in CFH. Gender should be considered in genetic studies of anterior
uveitis even extending to other immunologic diseases.
Uveitis is an intraocular inflammatory disease involving
the uveal tract and can be anatomically classified as anterior,
intermediate, posterior, and panuveitis [1]. Anterior uveitis
(AU) is the most common form, accounting for 50% to 92%
of cases in most Western countries and 28% to 50% in Asian
countries [2]. AU involves the anterior part of the uveal tract
and can be idiopathic or associated with other immunologic
disorders such as ankylosing spondylitis (AS) and rheumatoid
arthritis  (RA).  Although  the  exact  pathogenesis  of  AU  is
unclear, clinical and animal studies have demonstrated that
the inflammation in AU is regulated by various endogenous
immunological factors. In addition, an important conceptual
consideration is that the disease can manifest in individuals
with  genetic  predisposition  coupled  with  environmental
trigger [3,4]. AU is closely associated with human leukocyte
antigen (HLA)-B27, the major histocompatibility complex
(MHC) type I gene [5,6]. Gene polymorphisms of various
non-MHC genes such as cytokines and antioxidant enzyme
genes have also been implicated to play important roles in the
pathogenesis of AU [7-9].
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Interleukins are potent inflammatory mediators produced
by  white  blood  cells  and  play  important  roles  in  the
development of uveitis [10-16]. Studies have shown that the
levels of interleukin 2 (IL-2), interleukin 21 (IL-21) and their
receptors were upregulated in both experimental autoimmune
uveitis  (EAU)  animals  and  in  uveitis  patients  [10-13].
Recently, several studies have revealed that IL-27 expression
was upregulated during uveitis and retinal cells could suppress
uveitis through production of IL-27 [15,16]. Several single
nucleotide polymorphisms (SNPs) in interleukin genes have
been found to be associated with various types of uveitis but
only a few of them were found to have a strong association
[17-19].  In  recent  years, based on genome-wide association
study (GWAS), several candidate SNPs were successively
found to be associated with a range of immune-mediated
diseases, such as Behçet’s disease, type 1 diabetes mellitus,
RA, celiac disease, and Graves’ disease [20-24]. Some of
these  genetic  loci  were  replicated  reciprocally  in  various
diseases, implying that these loci might be the general risk
factors for multiple autoimmune diseases [25-27].
The complement system is another important pathway of
innate immunity. The   system   can be divided into the  classic,
lectin and alternative pathways and plays an important role in
many  immunological  diseases  including  uveitis.  Various
studies have demonstrated that the activation of complement
system  is  critical  for  the  development  of  experimental
autoimmune anterior uveitis (EAAU) and the depletion of the
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2655host’s complement system could result in complete inhibition
of  EAAU  [28,29].  Under  normal  conditions,  complement
system is continuously active at a low level and is tightly
regulated  by  intraocular  complement  regulatory  proteins
(CRegs)  such  as  complement  factor  H  (CFH),  decay-
accelerating factor and S-protein. Studies have shown that
suppression  of  CRegs  can  exacerbate  EAAU  due  to
unregulated complement activation [30,31]. CFH acts as a key
regulator  in  the  complement  alternative  pathway  and  is
involved in the pathogenesis of many immunological diseases
[32-34]. Recent studies have suggested that variants in the
CFH  gene,  as  well  as  in  the  genes  of  other  CFH-related
proteins  might  be  involved  in  many  immune-mediated
diseases [35-37]. We hypothesized that rs4505848 within the
KIAA1109/Testis nuclear RNA-binding protein (Tenr)/IL2/
IL21  gene  cluster,  rs4788084  in  IL-27,  and  rs800292  in
CFH  might  be  involved  in  the  pathogenesis  of  AU.  The
purpose of our study is to determine the association of these
immune-associated SNPs in Chinese patients with AU.
METHODS
Study design and subjects: Subjects were recruited from the
Hong Kong Eye Hospital. The study protocol was approved
by an institutional review board and all the procedures were
conducted  according  to  the  tenets  of  the  Declaration  of
Helsinki.  Informed  consent  was  obtained  from  all  study
subjects after explanation of the nature of the study.
All  patients  underwent  detailed  ocular  examination
including visual acuity, intraocular pressure, slit lamp, and
dilated  fundus  examinations.  Clinical  details  were  also
collected from the case notes including age, sex, medical
history such as systemic illness, age at initial presentation,
laterality,  pattern  of  anterior  uveitis  (acute,  recurrent  or
chronic),  clinical  features,  and  complications  of  AU.  The
definition of uveitis was based on the Standardization Uveitis
Nomenclature  (SUN)  classification  [38].  Acute  AU  was
defined as AU resolving completely within 3 months, chronic
AU as AU not fully resolved within 3 months, and recurrent
AU as the development of AU more than once. Patients with
any of the following situations were excluded from the study
(1) AU secondary to ocular or systemic infections; (2) AU
secondary to specific syndromes (e.g., Posner-Schlossman’s
syndrome, Fuchs’ uveitis, Vogt–Koyanagi–Harada (VKH) or
Behçet’s disease); (3) patients who were unable to cooperate
during ocular examination and with chronic uveitis at the
onset of the study. Three hundred and eight subjects aged 50
years  older  with  no  ophthalmic  eye  disease  except  senile
cataract were included as control subjects.
DNA extraction and genotyping: Venous blood was obtained
from each subject and genomic DNA was extracted with a
DNA  extraction  kit  (QIAamp;  Qiagen,  Hilden,  Germany)
according to the manufacturer’s instructions. CFH-rs800292,
KIAA1109-rs4505848,  and  IL27-rs4788084  SNPs  were
genotyped by TaqMan allelic discrimination assay (TaqMan;
TABLE 1. COMPARISON OF GENOTYPE AND ALLELE FREQUENCIES OF RS800292, RS4505848, AND RS4788084 POLYMORPHISMS IN PATIENTS WITH AU AND
CONTROL SUBJECTS.
Polymorphism Anterior uveitis (n=98) Controls (n=308) p-value Odds ratio
rs800292 (CFH 184G/A)
Genotype
AA 10 (10.2) 48 (15.6) 0.17§  
AG 42 (42.9) 145 (47.1) 0.091*  
GG 46 (46.9) 115 (37.3) 0.19‡  
Allele
A 62 (31.6) 241 (39.1) 0.059§ 1.39 (0.99–1.96)
G 134 (68.4) 375 (60.9)    
rs4505848 (KIAA1109 G/A)
Genotype
GG 12 (12.2) 50 (16.2) 0.42§  
AG 57 (58.2) 157 (51.0)    
AA 29 (29.6) 101 (32.8)    
Allele
G 81 (41.3) 257 (41.7) 0.92§
A 115 (58.7) 359 (58.3)    
rs4788084 (IL27 T/C)
Genotype
TT 9 (9.2) 21 (6.8) 0.74§  
CT 39 (39.8) 126 (40.9)    
CC 50 (51.0) 161 (52.3)    
Allele
T 57 (29.1) 168 (27.3) 0.62§
C 139 (70.9) 448 (72.7)    
          Data are the number of subjects (% of the total group). §χ2 test. *p-value for dominant model. ‡p-value for recessive model.
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2657Applied Biosystems [ABI], Foster City, CA) according to the
manufacturer’s  instructions.  All  PCR  amplifications  were
performed  with  the  following  thermal  cycling  conditions:
95 °C for 10 min followed by 40 cycles of 92 °C for 15 s, and
62 °C for 1.5 min (rs4505848 and rs4788084); and 60 °C for
1  min  (rs800292),  respectively.  The  HLA-B27  allele  was
detected by nested PCR as described by Konno et al. [39]. The
B locus of HLA was first amplified, the B27 allele was then
amplified from the diluted PCR product of the B locus by
using sequence-specific primers. The B27 allele was further
detected and confirmed as described previously [39]. All PCR
reactions were performed with Taq polymerase (HotStarTaq
Plus; Qiagen) in an automated thermal cycler (model 9700;
ABI). Pre- and post-PCR plate readings were performed on a
sequence detection system (Prism 7000; ABI), and the allele
types were confirmed by the system software (Prism 7000
SDS software version 1.1; ABI).
Statistical analysis: Hardy–Weinberg equilibrium (HWE) for
genotype frequencies of the SNPs in the control group were
tested  by  χ2  test.  The  genotype  frequencies  for  each
polymorphism were determined by direct counting and allele
frequencies  were  calculated.  Allelic  and  genotypic
frequencies  between  patients  with  AU  and  controls  were
compared  by  χ2  test.  Analyses  were  also  performed  by
stratifying AU patients based on gender and HLA-B27 status
and compared with control subjects. Odds ratios (OR) and
95% confidence intervals (CI) were calculated. Bonferroni
correction  was  applied  to  adjust  for  the  number  of
comparisons performed based on the total number of loci and
thus  a  p  value  of  0.017  was  considered  as  statistically
significant.
RESULTS
Patients demographics: Ninety-eight patients with AU were
recruited,  including  45  (45.9%)  males  and  53  (54.1%)
females. The mean±SD age of the patients was 49.7±16.0
years (range, 11–87 years). Forty-seven (48.0%) patients had
unilateral uveitis, and 51 (52.0%) had bilateral involvement.
Systemic diseases associated with the patients included AS
(n=19,  19.4%);  psoriasis  (n=1,  1.0%);  systemic  lupus
erythematosus (n=1, 1.0%); ulcerative colitis (n=1, 1.0%),
and interstitial nephritis (n=1, 1.0%). Ninety-two (93.9%)
patients had acute AU only, of which 59 (60.2%) had recurrent
episodes of AU, and 6 (6.1%) developed chronic AU after
acute episodes of AU.
Associations between SNPs and AU: All genotype frequencies
of the 3 SNPs in the control subjects conformed to the Hardy–
Weinberg equilibrium. There was no significant difference in
allelic  and  genotypic  frequencies  for  the  3  SNPs  (CFH-
rs800292, KIAA1109-rs4505848, and IL27-rs4788084) in AU
patients compared with controls. There was a trend toward
higher 184G allele frequency for rs800292 in AU patients
TABLE 3. COMPARISON OF GENOTYPE AND ALLELE FREQUENCIES OF RS800292, RS4505848, AND RS4788084 POLYMORPHISMS IN MALE PATIENTS WITH
AU AND MALE CONTROL SUBJECTS.
Polymorphism Male AU patients (n=45) Male controls (n=125) p-value
rs800292 (CFH 184G/A)
Genotype
AA 7 (15.6) 17 (13.6) 0.92§
AG 23 (51.1) 63 (50.4) 0.75*
GG 15 (33.3) 45 (36.0) 0.75‡
Allele
A 37 (41.1) 97 (38.8) 0.70§
G 53 (58.9) 153 (61.2)  
rs4505848 (KIAA1109 G/A)
Genotype
GG 5 (11.1) 23 (18.4) 0.52§
AG 25 (55.6) 62 (49.6)  
AA 15 (33.3) 40 (32.0)  
Allele
G 35 (38.9) 108 (43.2) 0.48§
A 55 (61.1) 142 (56.8)  
rs4788084 (IL27 T/C)
Genotype
TT 1 (2.2) 9 (7.2) 0.43§
CT 20 (44.4) 48 (38.4)  
CC 24 (53.3) 68 (54.4)  
Allele
T 22 (24.4) 66 (26.4) 0.72§
C 68 (75.6) 184 (73.6)  
          Data are the number of subjects (% of the total group). §χ2 test. *p-value for dominant model. ‡p-value for recessive model.
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2658compared with controls but the difference did not reach the
level  of  statistical  significance  (31.6%  versus  39.1%,
p=0.059; Table 1).
Associations between SNPs and AU stratified by gender and
clinical features: When the analyses were stratified on the
basis  of  gender,  there  was  a  significant  increase  in  the
frequency  of  184G  allele  and  GG  homozygosity  for  the
CFH-rs800292 SNP in female AU patients compared with
control  female  subjects  (p=0.003,  OR=2.10  and  p=0.009,
OR=2.28, respectively). However, similar difference was not
observed in male patients. For the KIAA1109-rs4505848 and
IL27-rs4788084, there was no significant difference in both
male and female AU patients compared with controls (Table
2 and Table 3). There was no significant difference in allelic
and  genotypic  frequencies  in  AU  patients  stratified  by
recurrence and laterality (Table 4 and Table 5).
Association  of  SNPs  genotypes  and  allele  frequencies
stratified by HLA-B27 status: Forty-two (42.9%) of the 98
patients  with  AU  were  HLA-B27-positive  and  fifty-six
(57.1%)  were  HLA-B27-negative.  When  analyzed  on  the
basis of HLA-B27 status, there was no significant difference
in allelic and genotypic frequencies for the 3 SNPs (CFH-
rs800292,  KIAA1109-rs4505848,  and  IL27-rs4788084)
between  either  HLA-B27-positive  or  HLA-B27-negative
patients compared with control subjects (Table 6).
DISCUSSION
In our study, we investigated the association of three immune-
associated SNPs in the CFH, KIAA1109, and IL27 in Chinese
patients with AU. Our results demonstrated there was a trend
toward higher 184G allele frequency in the CFH-rs800292
SNP among AU patients compared with controls. Although
the  difference  failed  to  reach  the  level  of  statistical
significance  (p=0.059),  the  findings  suggested  that  CFH
might be associated with the susceptibility of developing AU.
Since genetic and environmental factors might be associated
with some gender-specific differences in the severity and type
of immunological diseases, we therefore further evaluated the
association  stratified  by  gender.  Our  results  showed  a
significant increase in the frequency of 184G allele and GG
homozygousity in female AU patients compared with control
subjects. To our knowledge, the associations between genetic
variants in CFH and AU and the gender differences have not
been  described  previously.  Activated  complement  is  a
“double-edged sword” which might cause self-tissue damage
especially in a sensitive organs like the eyes and they must be
carefully  regulated  by  CRegs  such  as  CFH  [40].  CFH  is
located in the long arm of chromosome 1 (1q32), which is a
major  soluble  inhibitor  of  the  alternative  pathway  in
controlling complement activation [30]. Furthermore, in vivo
studies have revealed that human retinal pigment epithelial
(RPE)  cells  can  synthesize  and  express  CFH,  which
TABLE 4. COMPARISON OF GENOTYPE AND ALLELE FREQUENCIES OF RS800292, RS4505848, AND RS4788084 POLYMORPHISMS IN AU PATIENTS STRATIFIED
BY RECURRENCE STATUS.
Polymorphism Recurrent (n=59) Non-recurrent (n=39) p-value
rs800292 (CFH 184G/A)
Genotype
AA 5 (8.5) 5 (12.8) 0.38§
AG 23 (39.0) 19 (48.7)  
GG 31 (52.5) 15 (38.5)  
Allele
A 33 (28.0) 29 (37.2) 0.18§
G 85 (72.0) 49 (62.8)  
rs4505848 (KIAA1109 G/A)
Genotype
GG 7 (11.9) 5 (12.8) 0.51§
AG 32 (54.2) 25 (64.1)  
AA 20 (33.9) 9 (23.1)  
Allele
G 46 (39.0) 35 (44.9) 0.41§
A 72 (61.0) 43 (55.1)  
rs4788084 (IL27 T/C)
Genotype
TT 7 (11.9) 2 (5.1) 0.50§
CT 22 (37.3) 17 (43.6)  
CC 30 (50.8) 20 (51.3)  
Allele
T 36 (30.5) 21 (26.9) 0.59§
C 82 (69.5) 57 (73.1)  
               Data are the number of subjects (% of the total group). §χ2 test.
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2659upregulates various CRegs including CFH to suppress the
development of EAU [31,41,42].
In our previous study, we found SNP rs800292 in CFH
was associated with age-related macular degeneration (AMD)
in Chinese patients [43]. In addition, CFH has also been found
to be associated with other immune-mediated diseases such
as multifocal choroiditis, hemolytic-uremic syndrome (HUS)
and glomerulonephritis, where some risk loci overlap with
those of AMD [35,36]. In this study, the SNP rs800292 was
found to be associated with AU in female patients. The change
of G184A nucleotide of rs800292 in the CFH gene results in
the synthesis of Isoleucine instead of Valine at codon 62. This
might  lead  to  structural  changes  affecting  the  ability  of
complement component 3b (C3b) binding and reducing the
activation of the alternative pathway C3-convertase (C3bBb).
This  subsequently  causes  excessive  activation  of  the
complement system to induce immunologic disorder and the
gender bias may be due to different pathway of CFH in AU.
The exact mechanism is still unclear and further studies will
be needed to investigate the functional interaction of CFH and
AU and the difference in gender-susceptibility in AU.
SNP rs4505848 is in the region encompassing KIAA1109/
Tenr/IL2/IL21 which is located on the chromosome 4q27.
This 480 kB block of linkage disequilibrium includes IL2 and
IL21,  which  are  both  functional  candidate  loci  for
autoimmune diseases. As mentioned previously, levels of IL2,
IL21, and their receptors were significantly increased during
uveitis in patients and animal models and they may participate
in  the  regulation  of  T-cell  responses  [11-13].  Current
evidences indicated that both T helper 1 (Th1) and T helper
17 (Th17) effector cells can independently induce uveitis in
animal models [44,45]. Functional studies have revealed that
Th17  cells  contribute  to  uveitis  through  expanded  IL-2,
meanwhile IL-21 was highly expressed and promoted the
differentiation of Th17 cells both in vitro and in vivo studies
[13,15]. IL27 is a recently discovered cytokine belonging to
the  IL6/IL12  families,  which  consists  of  EBI3  and  p28
subunits. Studies have shown that IL27 was constitutively
expressed in retinal ganglion and photoreceptor cells in EAU
and  IL27  could  promote  Th1  but  inhibit  Th17  cells
differentiation, which lead to a mutual antagonism between
the two pathways [15].
Taken together, these studies indicate that IL2, IL21, and
IL27  play  important  roles  in  the  development  of  uveitis,
predicting an association of these two SNPs (rs4505848 and
rs4788084)  with  AU.  However  in  our  study,  no  such
association was found even stratified by gender. This might
be due to ethnic differences in susceptibility to AU; the small
number of subjects; the wide variety of AU syndromes; the
complex regulation mechanism in inflammatory activity, as
well as the candidate polymorphisms chosen among these
plausible genes. Therefore, further investigations are needed
in  more  subtypes  of  uveitis  and  other  ethnic  groups.  In
addition, considering HLA-B27 is the strongest association
TABLE 5. COMPARISON OF GENOTYPE AND ALLELE FREQUENCIES OF RS800292, RS4505848, AND RS4788084 POLYMORPHISMS STRATIFIED BY LATERALITY
STATUS.
Polymorphism Bilateral AU (n=51) Unilateral AU (n=47) p-value
rs800292 (CFH 184G/A)
Genotype
AA 4 (7.8) 6 (12.8) 0.70§
AG 23 (45.1) 19 (40.4)  
GG 24 (47.1) 22 (46.8)  
Allele
A 31 (30.4) 31 (33.0) 0.70§
G 71 (69.6) 63 (67.0)  
rs4505848 (KIAA1109 G/A)
Genotype
GG 7 (13.7) 5 (10.6) 0.55§
AG 27 (52.9) 30 (63.8)  
AA 17 (33.3) 12 (25.5)  
Allele
G 41 (40.2) 40 (42.6) 0.74§
A 61 (59.8) 54 (57.4)  
rs4788084 (IL27 T/C)
Genotype
TT 4 (7.8) 5 (10.6) 0.53§
CT 23 (45.1) 16 (34.0)  
CC 24 (47.1) 26 (55.3)  
Allele
T 31 (30.4) 26 (27.7) 0.67§
C 71 (69.6) 68 (72.3)  
               Data are the number of subjects (% of the total group). §χ2 test for 2×3.
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2661with AU and the interaction with these immune-associated
genes, further analyses were performed in these AU patients
stratified by HLA-B27 status. We found all the 3 SNPs were
not associated with AU regardless of HLA-B27 positivity.
The exact reason is unclear but it may account for the weaker
association of these SNPs with AU, or the influence of these
genes on AU independent on HLA-B27.
In conclusion, we found the association of CFH 184G
with AU in Chinese female patients. The genetic association
between the complement system and AU was identified with
gender  susceptibility.  Further  studies  to  replicate  the
candidate SNPs in others ethnic groups and determine the
biologic  roles  of  these  polymorphisms  in  immune
mechanisms involved in uveitis are worthwhile.
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